Autori: Elstein Deborah
| Naslov | Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease (Article) |
| Autori | van Dussen Laura Zimran An Akkerman EM Aerts JMFG Petakov Milan S Elstein Deborah Rosenbaum H Aviezer David Brill-Almon Einat Chertkoff Raul Maas M Hollak CEM |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2013), vol. 50 br. 3, str. 206-211 |
| Projekat | Protalix Biotherapeutics |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction (Article) |
| Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran Ari |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2011), vol. 47 br. 1, str. 56-61 |
| Projekat | Shire Human Genetic Therapies ; Protalix Therapeutics ; Genzyme Corporation |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease (Article) |
| Autori | Elstein Deborah Cohn Gabriel M Wang N Djordjevic Maja S Brutaru Costin Zimran An |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2011), vol. 46 br. 1, str. 119-123 |
| Projekat | Shire Human Genetic Therapies ; Genzyme Corporation ; Shire HGT |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
